FDA Import Refusal AEK-2087812-9/10003/1 — TORRENT PHARMACEUTICALS
The FDA refused shipment AEK-2087812-9/10003/1 from TORRENT PHARMACEUTICALS (India) on Sep 30, 2026. The refused product falls under Drugs and Biologics — DABIGATRAN ETEXILATE MESYLATE (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 30, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61LCY41 DABIGATRAN ETEXILATE MESYLATE (ANTI-COAGULANT)
- Charges
- 75